Molecular Haematology

JAK2, CALR, MPL, SF3B1, KIT, CSF3R, ETNK1, SH2B3, ASXL1, CBL, EZH2, IDH1, IDH2, KRAS, NRAS, RUNX1, SETBP1, SRSF2, TET2, TP53, U2AF1, ZRSR2.  

$475 (non-MBS eligible) 

$357 (MBS item 73398) 

$612.10 (MBS item 73399) 

Preferred samples: 4 ml peripheral blood (EDTA) OR 1-2 ml bone marrow (EDTA) 

TAT: 21 days 

Methodology: Next Generation Sequencing (NGS)  

ABL1, ARAF, ASXL1, BAX, BCL2, BCOR, BCORL1, BIRC3, BRAF, BTK, CALR, CARD11, CBFB, CBL, CCND1, D274, CD79B, CEBPA, CSF3R, CXCR4, DDX3X, DDX41*, DNMT3A, EGR2, ETNK1, ETV6, EZH2, FLT3, FYN, GATA1, GATA2, ID3, IDH1, IDH2, IRF8, JAK1, JAK2, JAK3, KIT, KRAS, MAP2K1, MEN1, MPL, MYD88, NF1, NFKBIE, NOTCH1, NOTCH2, NPM1, NRAS, PDCD1LG2, PDGFRA, PIGA, PIK3CD, PLCG1, PLCG2, PPM1D, PTEN, PTPN11, RHOA, RRAGC, RUNX1, SETBP1, SF3B1, SH2B3, SMARCA2, SMARCA4, SRSF2, STAG2, STAT3, STAT5B, STAT6, TET2, TP53, U2AF1, UBA1, UBTF, WT1, XPO1, ZRSR2

*Excluded on request.  

**FLT3-ITD included when requested  

$829.10 (fully covered by MBS item no. 73447/73448)

Preferred samples:  

4 ml peripheral blood (EDTA);  

1-2 ml bone marrow (EDTA); 

Tissue – fresh or FFPE block/slides (10 x 5 micron sections on positively charged slides) 

TAT: 21 days 

Methodology: Next Generation Sequencing (NGS)  

ABL1, ABL2, AFDN, AFF1, ALK, BCL11B, BCR, BRAF, CBFA2T3, CBFB, CPSF6, CREBBP, CRLF2, CSF1R, DEK, ELL, EPOR, ERG, ETV6, FGFR1, FGFR3, FIP1L1, FLT3, FUS, GLIS2, HLF, IL2RB, JAK2, KAT6A, KMT2A, MECOM, MEF2D, MLF1, MLLT1, MLLT10, MLLT11, MLLT3, MNX1, MRTFA, MYB, MYC, MYH11, NPM1, NTRK1, NTRK2, NTRK3, NUP214, NUP98, NUTM1, PAX5, PBX1, PCM1, PDCD1LG2, PDGFRA, PDGFRB, PICALM, PML, PTK2B, RARA, RARG, RBM15, RET, RUNX1, RUNX1T1, TCF3, TSLP, TYK2, UBTF, USP2, ZMYM2, ZNF384

 $700 (MBS eligible under DNA&RNA item no. 73445/73446)

Preferred samples:

20ml peripheral blood (EDTA);

1-2ml bone marrow (EDTA)

Tissue - fresh or FFPE block/slides (10 x 5 micron sections on positively charged slides)

TAT: 21 days

Methodology: Next Generation Sequencing (NGS)

$196.35 (non-MBS eligible) 

Fully covered (MBS item 73314) 

Preferred samples:  

4 ml peripheral blood (EDTA) OR 1-2 ml bone marrow (EDTA) 

TAT: 7 days 

Methodology: Fragment analysis by capillary electrophoresis  

$196.35 (non-MBS eligible) 

Fully covered (MBS item 73314) 

Preferred samples:  

4 ml peripheral blood (EDTA) OR 1-2 ml bone marrow (EDTA) 

TAT: 7 days 

Methodology: Fragment analysis by capillary electrophoresis  

$196.35 (non-MBS eligible) 

Fully covered (MBS item 73314) 

Preferred samples:  

20 ml peripheral blood (EDTA) OR 1-2 ml bone marrow (EDTA).  

Sample must be received within 72 hours of collection. 

TAT: 7 days 

Methodology: reverse transcription quantitative PCR (RT-qPCR) 

Type A, B or D 

$196.35 (non-MBS eligible) 

Fully covered (MBS item 73314) 

Preferred samples:  

20 ml peripheral blood (EDTA) OR 1-2 ml bone marrow (EDTA).  

Sample must be received within 72 hours of collection.  

TAT: 14 days 

Methodology: reverse transcription quantitative PCR (RT-qPCR)  

$129 (not MBS covered) 

Preferred samples:  

4 ml (pre-transplant)/ 18 ml (post-transplant) peripheral blood (EDTA) OR  

1-2 ml bone marrow (EDTA).  

Post-transplant samples must be received within 72 hours of collection.  

TAT: 14 days 

Methodology: Short tandem repeat (STR) fragment analysis by capillary electrophoresis  

$550 (not MBS covered)

Preferred samples: 

4 ml peripheral blood (EDTA) OR 1-2 ml bone marrow (EDTA) 

TAT: 28 days  

$250 (not MBS covered) 

Preferred samples:  

4 ml peripheral blood (EDTA) OR 1-2 ml bone marrow (EDTA) 

TAT: 28 days 

Methodology: Sanger sequencing 

$37.50